Breaking News Instant updates and real-time market news.

SGEN

Seattle Genetics

$54.24

0.97 (1.82%)

, CASC

Acquired by SGEN

$10.00

0.03 (0.30%)

07:11
02/07/18
02/07
07:11
02/07/18
07:11

H.C. Wainwright ups Seattle Genetics target to $77 on tumor pipeline

Seattle Genetics' (SGEN) solid tumor pipeline is the "most interesting value driver" with three late-stage programs that could expand the company's footprint beyond hematology, H.C. Wainwright analyst Andrew Fein tells investors in a research note titled "Looking Ahead With a Solid Tumor Play." The analyst believes the recent acquisition of Cascadian Therapeutics (CASC) and the HER2+ breast cancer asset, tucatinib, further supports the view that Seattle Genetics is "throwing more weight behind the expansion/diversification from the hematologic malignancies territory into the solid tumor domain." Fein raised his price target for the shares to $77 from $75 and reiterates a Buy rating on the name.

SGEN

Seattle Genetics

$54.24

0.97 (1.82%)

CASC

Acquired by SGEN

$10.00

0.03 (0.30%)

  • 08

    Feb

  • 26

    Feb

  • 01

    May

SGEN Seattle Genetics
$54.24

0.97 (1.82%)

01/31/18
RAJA
01/31/18
DOWNGRADE
RAJA
Market Perform
Raymond James sees no other bidders, downgrades Cascadian after deal
Raymond James analyst Reni Benjamin downgraded Cascadian Therapeutics (CASC) to Market Perform from Outperform after the company agreed to be acquired by Seattle Genetics (SGEN) for $10 per share. The acquisition is "great news" for Cascadian shareholders as it unlocks the risk-adjusted value of tucatinib immediately, Benjamin tells investors in a research note. He views the proposed acquisition as a "fair deal" and expects no competing bidders to emerge.
01/31/18
RAJA
01/31/18
DOWNGRADE
RAJA
Market Perform
Cascadian Therapeutics downgraded to Market Perform at Raymond James
Raymond James downgraded Cascadian Therapeutics (CASC) to Market Perform from Outperform after Seattle Genetics (SGEN) announced it has reached a deal to acquire Cascadian for $10 per share in cash.
01/31/18
PIPR
01/31/18
NO CHANGE
Target $55
PIPR
Neutral
Seattle Genetics acquisition adds late-stage cancer drug, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff says Seattle Genetics' (SGEN) "surprise" acquisition of Cascadian Therapeutics (CASC) adds a late-stage cancer drug and also expands the company beyond its antibody-drug conjugate focus. To pay for the deal, Seattle Genetics is aiming to raise $550M, Tenthoff tells investors in a research note. He keeps a Neutral rating on the shares with a $55 price target.
12/12/17
CANT
12/12/17
NO CHANGE
Target $50
CANT
Neutral
Cantor sees Seattle Genetics shares struggling in near-term
Cantor Fitzgerald analyst Mara Goldstein notes shares of Seattle Genetics dropped 7% yesterday after data presentations, including full release of Echelon-1, which showed a modest improvement in modified progression free survival and reduced pulmonary toxicity versus standard of care, but also with increases in neuropathy. The analyst sees the stock struggling to gain greater value for Echelon-1 as she believes Adcetris expectations already include growth that incorporates additional indications. Goldstein sees valuation expansion being driven by the pipeline, but does not see near-term catalysts on that front. The analyst keeps a Neutral rating on Seattle Genetics with a $50 price target.
CASC Acquired by SGEN
$10.00

0.03 (0.30%)

09/06/17
LEHM
09/06/17
INITIATION
LEHM
Underweight
Cascadian Therapeutics initiated with an Underweight at Barclays
Barclays initiated Cascadian with an Underweight rating and a $4 price target, citing a lack of any major catalysts in the next two to three years.

TODAY'S FREE FLY STORIES

LITE

Lumentum

$41.92

-2.81 (-6.28%)

, OCLR

Oclaro

$8.27

-0.165 (-1.96%)

18:16
12/09/18
12/09
18:16
12/09/18
18:16
Periodicals
Huawei CFO seeking bail, Reuters reports »

Huawei Chief Financial…

LITE

Lumentum

$41.92

-2.81 (-6.28%)

OCLR

Oclaro

$8.27

-0.165 (-1.96%)

FNSR

Finisar

$22.49

-0.53 (-2.30%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

INFN

Infinera

$4.38

-0.21 (-4.58%)

CIEN

Ciena

$31.30

-0.95 (-2.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

KERX

Keryx

$3.14

-0.035 (-1.10%)

, AKBA

Akebia

$8.52

-0.02 (-0.23%)

16:51
12/09/18
12/09
16:51
12/09/18
16:51
Conference/Events
Akebia to host special shareholder meeting »

Special Shareholder…

KERX

Keryx

$3.14

-0.035 (-1.10%)

AKBA

Akebia

$8.52

-0.02 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

AKBA

Akebia

$8.52

-0.02 (-0.23%)

, KERX

Keryx

$3.14

-0.035 (-1.10%)

16:49
12/09/18
12/09
16:49
12/09/18
16:49
Conference/Events
Keryx to host special shareholder meeting »

Special Shareholder…

AKBA

Akebia

$8.52

-0.02 (-0.23%)

KERX

Keryx

$3.14

-0.035 (-1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

DVMT

Dell Technologies

$104.01

-1.51 (-1.43%)

16:35
12/09/18
12/09
16:35
12/09/18
16:35
Conference/Events
Dell Technologies to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 07

    Mar

T

AT&T

$30.14

-0.38 (-1.25%)

, CMCSA

Comcast

$37.41

-0.46 (-1.21%)

16:34
12/09/18
12/09
16:34
12/09/18
16:34
Hot Stocks
Box Office Battle: 'Ralph Breaks the Internet' leads top office with $16.1M »

Disney's (DIS)…

T

AT&T

$30.14

-0.38 (-1.25%)

CMCSA

Comcast

$37.41

-0.46 (-1.21%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$51.19

-0.67 (-1.29%)

FOX

21st Century Fox

$48.99

-0.23 (-0.47%)

FOXA

21st Century Fox

$49.26

-0.21 (-0.42%)

LGF.A

Lionsgate

$17.58

0.28 (1.62%)

DIS

Disney

$112.00

-1.385 (-1.22%)

VIAB

Viacom

$29.91

-0.09 (-0.30%)

VIA

Viacom

$33.19

0.11 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 30

    Jan

  • 20

    Mar

CNC

Centene

$133.28

-2.1 (-1.55%)

16:09
12/09/18
12/09
16:09
12/09/18
16:09
Conference/Events
Centene to hold a meeting »

2019 Financial Guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

FTI

TechnipFMC

$21.00

-0.69 (-3.18%)

16:00
12/09/18
12/09
16:00
12/09/18
16:00
Conference/Events
TechnipFMC to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRX

Catalyst Pharmaceuticals

$2.39

0.16 (7.17%)

15:56
12/09/18
12/09
15:56
12/09/18
15:56
Conference/Events
Catalyst Pharmaceuticals to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

WPP

WPP

$52.11

-0.39 (-0.74%)

14:22
12/09/18
12/09
14:22
12/09/18
14:22
Conference/Events
WPP to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

VISI

Volt Information Sciences

$2.64

-0.05 (-1.86%)

14:11
12/09/18
12/09
14:11
12/09/18
14:11
Conference/Events
Volt Information Sciences to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ARCT

Arcturus Therapeutics

$5.90

0.45 (8.26%)

13:52
12/09/18
12/09
13:52
12/09/18
13:52
Conference/Events
Arcturus Therapeutics to hold a conference call »

Key Opinion Leader…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

STWD

Starwood Property

$22.34

-0.08 (-0.36%)

13:37
12/09/18
12/09
13:37
12/09/18
13:37
Conference/Events
Starwood Property to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

EZPW

Ezcorp

$8.74

-0.17 (-1.91%)

13:31
12/09/18
12/09
13:31
12/09/18
13:31
Conference/Events
Ezcorp to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

NFLX

Netflix

$265.14

-17.66 (-6.24%)

, PANW

Palo Alto Networks

$175.11

-6.73 (-3.70%)

13:20
12/09/18
12/09
13:20
12/09/18
13:20
Periodicals
Netflix, Palo Alto offer growth at a discount, Barron's says »

As stocks search for a…

NFLX

Netflix

$265.14

-17.66 (-6.24%)

PANW

Palo Alto Networks

$175.11

-6.73 (-3.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 19

    Dec

  • 09

    Jan

  • 10

    Jan

DHR

Danaher

$101.94

-2.88 (-2.75%)

13:18
12/09/18
12/09
13:18
12/09/18
13:18
Conference/Events
Danaher to host analyst and investor meeting »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

CIEN

Ciena

$31.30

-0.95 (-2.95%)

, INFN

Infinera

$4.38

-0.21 (-4.58%)

12:37
12/09/18
12/09
12:37
12/09/18
12:37
Periodicals
China urges Canada to free Huawei CFO, Reuters reports »

China warned Canada that…

CIEN

Ciena

$31.30

-0.95 (-2.95%)

INFN

Infinera

$4.38

-0.21 (-4.58%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

FNSR

Finisar

$22.49

-0.53 (-2.30%)

OCLR

Oclaro

$8.27

-0.165 (-1.96%)

LITE

Lumentum

$41.92

-2.81 (-6.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

VLKAY

Volkswagen

$0.00

(0.00%)

12:34
12/09/18
12/09
12:34
12/09/18
12:34
Periodicals
Volkswagen denies chairman knew early about emission cheating, Reuters says »

Volkswagen has denied…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$263.68

-5.98 (-2.22%)

12:29
12/09/18
12/09
12:29
12/09/18
12:29
Periodicals
U.S. says March 1 'hard deadline' for deal with China, Reuters reports »

U.S.-China trade…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$263.68

-5.98 (-2.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLUU

Glu Mobile

$7.08

-0.32 (-4.32%)

, RMBL

RumbleON

$6.04

-0.11 (-1.79%)

05:55
12/09/18
12/09
05:55
12/09/18
05:55
Conference/Events
Roth Capital to hold a conference »

7th Annual ROTH Utah…

GLUU

Glu Mobile

$7.08

-0.32 (-4.32%)

RMBL

RumbleON

$6.04

-0.11 (-1.79%)

SSTI

ShotSpotter

$35.09

-1.2 (-3.31%)

QTNA

Quantenna Communications

$14.68

-0.33 (-2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 06

    Jan

ZYME

Zymeworks

$13.15

(0.00%)

12:57
12/08/18
12/08
12:57
12/08/18
12:57
Hot Stocks
Zymeworks submits IND application for ZW49, presents IND-enabling studies »

Zymeworks presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$42.00

-0.43 (-1.01%)

12:37
12/08/18
12/08
12:37
12/08/18
12:37
Periodicals
Lennar too cheap to pass up, Barron's says »

Few sectors of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$8.74

-0.155 (-1.74%)

12:34
12/08/18
12/08
12:34
12/08/18
12:34
Periodicals
Time to bail out of Deutsche Bank, Barron's says »

There is not much to love…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$123.54

-4.69 (-3.66%)

12:30
12/08/18
12/08
12:30
12/08/18
12:30
Periodicals
Caterpillar stock prospects 'are bright,' Barron's says »

If there's such a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMW

VMware

$159.34

-3.16 (-1.94%)

, DVMT

Dell Technologies

$104.01

-1.51 (-1.43%)

12:26
12/08/18
12/08
12:26
12/08/18
12:26
Periodicals
Michael Dell deal could yield cheap new stock, Barron's says »

The curtain is likely to…

VMW

VMware

$159.34

-3.16 (-1.94%)

DVMT

Dell Technologies

$104.01

-1.51 (-1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 10

    Jan

AMAT

Applied Materials

$33.65

-1.04 (-3.00%)

12:23
12/08/18
12/08
12:23
12/08/18
12:23
Periodicals
Applied Materials a 'cheap bet' on big data, Barron's says »

Applied Materials has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.